Circulating D-dimer level is a predictor of overall survival and correlates with clinicopathologic characteristics of patients with neuroblastoma

Yun Chen,Yong Chai,Hui Huang,Min Zhang,Shouhua Zhang

2018-11-01

Abstract:Neuroblastoma (NB) is a relatively common pediatric malignancy. However, few validated blood biomarkers are available for clinical use. Here we retrospectively explored the significance of D-dimer levels of 81 patients with NB as a function of their clinicopathologic characteristics and overall survival (OS). We found that D-dimer levels were significantly associated with high-risk factors such as advanced disease stage and MYCN amplification. Higher D-dimer levels were observed in patients with stage 4 disease compared with those with stages 1-3 and s4 NB (P=0.004) and in those with amplified MYCN (P=0.041). However, no significant differences were found for sex (P=0.584) or age (≥12 months vs <12 months, P=0.201). Three-year OS was shorter for patients with higher D-dimer levels (≥0.72 mg/L; P=0.031). Multivariate analyses identified higher D-dimer levels (≥0.72 mg/L) as an independent predictor of poor OS (HR: 4.78, 95% CI: 1.98-16.1, P=0.018). Therefore, elevated D-dimer levels may serve to predict prognosis of patients with NB.